EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Lead-Attributable Cardiovascular Disease Burden

GBD 2023 Lead Collaborators, Jeffrey D Stanaway, Sandra Spearman, Nicole K DeCleene, Vanessa Garcia, Laura Lara-Castor, Stephen S Lim, Christopher J L Murray, Gregory A Roth, Matthew A Seymour, Benjamin Stark, Michael Brauer

JAMA · 28.04.2026 · 335 (16) · 1418

DOI: 10.1001/jama.2026.2197 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JAMA, erschienen am 28.04.2026. Verfasst von GBD 2023 Lead Collaborators und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, Seattle, Washington. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Global Burden of Disease, Lead, Nutrition Surveys. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Despite declines, lead exposure remains a major risk factor for cardiovascular disease (CVD) mortality. Quantifying the direct effects of cumulative bone lead exposure on CVD is essential to guide prevention and policy.

Objectives

To estimate the association between bone lead levels and CVD, derive an exposure-response curve, and estimate global, regional, and national lead-attributable disease burden for 1990 to 2023. Design, Setting, and Participants Analysis of 42 028 adults from 9 cycles of the US National Health and Nutrition Examination Survey (NHANES) spanning 1988 through 2013, with follow-up through December 2015 capturing 1748 CVD deaths, was combined with a systematic review and meta-regression. Bone lead was estimated from blood lead, age, and cohort-specific exposure histories. Cox proportional hazards models adjusted for blood pressure and confounders estimated hazard ratios for CVD mortality. A bayesian meta-regression using the Burden of Proof framework pooled NHANES results with published data to estimate the risk curve, which was then applied to lead exposure and CVD estimates to estimate population-attributable fractions and lead-attributable CVD burden. Exposure Estimated bone lead levels. Main Outcomes and Measures Lead-attributable CVD mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) by age, sex, year, and location.

Results

NHANES participants were aged 18 to 90 years (median, 46 [IQR, 32-63] years) and 51.5% of participants were female, with estimated bone lead levels ranging from 0.17 μg/g to 301 μg/g (median, 13.3 μg/g). Higher bone lead levels were associated with higher CVD risk: relative to estimated preindustrial levels of 0.027 μg/g, bone lead levels of 5 μg/g, 10 μg/g, 25 μg/g, 50 μg/g, and 100 μg/g corresponded to 7.5% (95% uncertainty interval [UI], 1.7%-14.1%), 15.8% (95% UI, 12.7%-19.1%), 41.3% (95% UI, 34.2%-49.2%), 71.3% (95% UI, 55.4%-90.0%), and 87.9% (95% UI, 61.0%-121.2%) greater CVD mortality risk, respectively. Globally in 2023, 3.5 million (95% UI, 2.6 million to 4.4 million) deaths and 71.6 million (95% UI, 52.4 million to 90.3 million) DALYs were attributable to lead exposure, accounting for 5.8% (95% UI, 4.3%-7.2%) of all deaths and 2.6% (95% UI, 1.8%-3.2%) of all DALYs. Lead was the eighth leading risk for global mortality and second leading environmental risk. Conclusions and Relevance Cumulative lead exposure remains a major, preventable contributor to global CVD mortality. Strengthened surveillance, regulation, and remediation are urgently required to reduce the lead-attributable burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesGlobal Burden of DiseaseLeadNutrition SurveysAdultAgedFemaleHumansMaleMiddle AgedBayes TheoremBone and BonesDisability-Adjusted Life YearsProportional Hazards ModelsUnited StatesFollow-Up StudiesHeart Disease Risk FactorsEnvironmental ExposureYoung AdultAged, 80 and overAdolescentEnvironmental Pollutants

Substanzen

LeadEnvironmental Pollutants

Autor:innen und Institutionen

  • Department of Health Metrics Sciences, Institute for Health Metrics and Evaluation, Seattle, Washington.

Zitieren

APA

GBD 2023 Lead Collaborators, Stanaway, J. D., Spearman, S., DeCleene, N. K., Garcia, V., Lara-Castor, L., Lim, S. S., Murray, C. J. L., Roth, G. A., Seymour, M. A., Stark, B., & Brauer, M. (2026). Lead-Attributable Cardiovascular Disease Burden. JAMA, 335(16), 1418. https://doi.org/10.1001/jama.2026.2197

Vancouver

GBD 2023 Lead Collaborators, Stanaway JD, Spearman S, DeCleene NK, Garcia V, Lara-Castor L, et al. Lead-Attributable Cardiovascular Disease Burden. JAMA. 2026;335(16):1418. doi:10.1001/jama.2026.2197

BibTeX
@article{GBDLeadCollaborators2026,
  author = {GBD 2023 Lead Collaborators, GBD 2023 Lead Collaborators and Stanaway, Jeffrey D and Spearman, Sandra and DeCleene, Nicole K and Garcia, Vanessa and Lara-Castor, Laura and Lim, Stephen S and Murray, Christopher J L and Roth, Gregory A and Seymour, Matthew A and Stark, Benjamin and Brauer, Michael},
  title = {Lead-Attributable Cardiovascular Disease Burden},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {16},
  pages = {1418},
  doi = {10.1001/jama.2026.2197}
}
Kostenlos starten →